COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Lindsey E. Roeker, Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander R. Coltoff, Matthew S. Davids, Peter O. Baker, Lori Leslie, Kerry A. Rogers, John N. Allan, Raul Cordoba, Alberto Lopez-Garcia, Darko Antic, John M. Pagel, Nicolas Martinez-Calle, José Antonio García-Marco, Jose Ángel Hernández-Rivas, Fatima Miras, Catherine C. Coombs, Anders ÖsterborgLotta Hansson, Amanda N. Seddon, Javier López Jiménez, Matthew R. Wilson, Dima El-Sharkawi, Daniel Wojenski, Shuo Ma, Talha Munir, Susana Valenciano, Erlene Seymour, Paul M. Barr, Jeffrey Pu, Piers E.M. Patten, Guilherme F. Perini, Scott F. Huntington, Helen Parry, Suchitra Sundaram, Alan Skarbnik, Manali Kamdar, Ryan Jacobs, Harriet Walter, Renata Walewska, Angus Broom, Sonia Lebowitz, Krista M. Isaac, Craig A. Portell, Inhye E. Ahn, Chaitra S. Ujjani, Mazyar Shadman, Sigrid Skånland, Elise A. Chong, Anthony R. Mato*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Scopus citations
Original languageEnglish (US)
Pages (from-to)1768-1773
Number of pages6
JournalBlood
Volume138
Issue number18
DOIs
StatePublished - Nov 4 2021

Funding

This research was supported, in part, by National Institutes of Health, National Cancer Institute Cancer Center support grant P30 CA008748. L.E.R. was supported by an American Society of Hematology Research Training Award for Fellows outside of the submitted work. I.E.A. receives research support from the Intramural Program of the National Heart, Lung, and Blood, Institute and an American Society of Hematology Scholar Award. T.A.E. was supported by the Oxford National Institute for Health Research (NIHR) Biomedical Research Centre.

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this